– USA, NY – PreciseDx, a leading innovator in AI-powered, patient-specific disease analysis, today announced the appointment of Paul Roma as Chairman of the Board of Directors, bringing decades of experience in corporate leadership and healthcare technology to the Board.
“We are delighted to have Paul join the PreciseDx board of directors as we work to positively impact patient outcomes through our technology and its ability to be accessed by anyone, anywhere. Paul brings invaluable expertise in healthcare transformation and technology, specifically in the areas of artificial intelligence (AI) and data, which will be integral to the next phase of our growth,” said CEO, Wayne Brinster.
Paul Roma joins a distinguished group of board members, including Eric Converse, CEO at AMRA Medical; Molly Harper, CBO for Synlogic, Inc.; and Erik Lium, CCIO at Mount Sinai Health System.
About Paul Roma
For more than two decades, Paul Roma has been working to transform healthcare around the world by applying next-generation technologies, such as data, analytics, and advanced AI to address the most pressing health challenges. He has partnered with industry leaders in healthcare – including Memorial Sloan Kettering, Mayo Clinic, the Broad Institute of MIT, and Harvard, among others in life sciences, insurance, and technology – to research, develop, train, and test game-changing technologies. Roma currently serves as a Senior Advisor at Francisco Partners — a leading technology investment firm — and has held previous leadership roles at IBM, where he was the General Manager of Watson Health, and Ciox Health, where he served as CEO.
“I am very excited to assume the role of Chairman of the PreciseDx Board of Directors and am pleased to work alongside the Company’s expert leadership team,” said Paul Roma. “PreciseDx has shown tremendous potential in its ability to improve patient outcomes and healthcare through AI-powered, patient-specific risk information. I look forward to helping the PreciseDx team continue to enhance and advance its offerings as part of making healthcare more precise and personalized.”
About PreciseDx
PreciseDx is a leading innovator in AI-powered, patient-specific disease analysis. PreciseDx’s Morphology Feature Array provides clinical teams with unmatched information and accurate, actionable intelligence for disease state characterization, supporting personalized patient management.
For more information: https://precisedx.ai/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.